ABSTRACT
Manuel Bardiès supervises the Radionuclide Dosimetry group within the Oncology Research Department (INSERM Unit 892, Nantes, France). He joined the French National Institute of Health and Medical Research (INSERM) in 1992 after earning his PhD in radiological physics from the University Paul Sabatier, Toulouse, France. The development and supervision of the group is made in tight coordination between the other research groups within the department (chemistry, radiopharmacy, radiobiology) and with the clinical departments in both the Nantes Cancer Center and the University Hospital. Research activities are being car-
ried out in different institutions, including Nantes National Veterinary School for preclinical imaging experiments. Radiopharmaceutical dosimetry is addressed at different scales, including cell microdosimetry for alpha radioimmunotherapy, small animal imaging and dosimetry, and participation to targeted radiotherapy clinical trials. Achievements in radiopharmaceutical dosimetry include the development of several dosimetry clinical trials, the setup of a modeling computing platform (48 nodes computer cluster) for MonteCarlo-based dosimetry (Oedipe), and camera modeling (Gate). The group is involved in the development of Gate and Manuel Bardiès is a member of the openGate collaboration steering committee. He has also been a member of the European Association of Nuclear Medicine (EANM) dosimetry committee since 2001 and is a member of several other scienti c societies. Dr. Bardiés has authored more than 30 publications and has given many invited lectures at national and international meetings (EANM, International Atomic Energy Agency [IAEA], European Society for Therapeutic Radiology and Oncology [ESTRO]).
